Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells
about
Attenuation of PTEN increases p21 stability and cytosolic localization in kidney cancer cells: a potential mechanism of apoptosis resistance.Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2An emerging role for TOR signaling in mammalian tissue and stem cell physiologyFoxOs cooperatively regulate diverse pathways governing neural stem cell homeostasisCytotoxicity of apigenin on leukemia cell lines: implications for prevention and therapymTOR: from growth signal integration to cancer, diabetes and ageingmTOR signaling in growth control and diseaseCXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progressionCXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenograftsHigher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIBEfficient tumour formation by single human melanoma cellsFoxO3 regulates neural stem cell homeostasisAnti-Cancer Stem-like Cell Compounds in Clinical Development - An Overview and Critical AppraisalThe Role of PTEN in Myeloid MalignanciesInflammation as a Keystone of Bone Marrow Stroma Alterations in Primary MyelofibrosisRedox Modulating NRF2: A Potential Mediator of Cancer Stem Cell ResistanceCancer stem cell targeted therapy: progress amid controversies.Phosphatase and Tensin Homologue: Novel Regulation by Developmental SignalingRedox Regulation in Cancer Stem CellsAutophagy in stem cells.The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?To breathe or not to breathe: the haematopoietic stem/progenitor cells dilemmaReactive oxygen species in cancer stem cellsRedox regulation of stem/progenitor cells and bone marrow nicheThe androgen receptor and stem cell pathways in prostate and bladder cancers (review)Emerging therapeutic biomarkers in endometrial cancerAdvances in understanding the leukaemia microenvironmentReactive oxygen species adversely impacts bone marrow microenvironment in diabetesNutrient-sensing pathways and metabolic regulation in stem cellsGSK-3 as potential target for therapeutic intervention in cancerRole of Microenvironment in Resistance to Therapy in AMLPTEN-deficient intestinal stem cells initiate intestinal polyposis.STAT5-regulated microRNA-193b controls haematopoietic stem and progenitor cell expansion by modulating cytokine receptor signalling.Oncogenic Kras initiates leukemia in hematopoietic stem cellsThe C-terminal CGHC motif of protein disulfide isomerase supports thrombosis.Update on acute myeloid leukemia stem cells: New discoveries and therapeutic opportunitiesJudicious Toggling of mTOR Activity to Combat Insulin Resistance and Cancer: Current Evidence and PerspectivesIn vitro models of cancer stem cells and clinical applicationsTargeting Strategies for Renal Cell Carcinoma: From Renal Cancer Cells to Renal Cancer Stem CellsCancer stem cells in basic science and in translational oncology: can we translate into clinical application?
P2860
Q21093282-DBB8D0B6-A806-4BD4-B0FC-8E833FF36CF2Q24628857-F582EA28-49D0-4296-BCCC-2D456BE8E871Q24629305-5568EB2C-D107-4FBA-A70B-77495EB35F43Q24630630-2592D6AB-3166-4AE9-B409-2031D6BEDFE9Q24631417-EAAAB9EB-DBD2-4875-BADB-F30586193156Q24633662-A3E252C0-18F2-4BCA-A745-85F79AC914C9Q24634174-BCB07555-D5CC-491C-9052-046AD77ADCCBQ24635943-33B71A09-A820-4D68-B980-13B76D0FC8B8Q24642170-AC717F0B-1C9D-4BE7-A24F-F610234DA153Q24645020-5CD613F5-0B43-4730-8AEE-D99961B6BBACQ24648938-4D17B857-4174-4959-8AD7-D6836AF8EEC8Q24658086-95E5BC2E-E55E-49A0-91EA-9E7FCCB2CEEDQ26744536-F682E631-14EC-4048-9252-CDCF1A24AA7AQ26770608-5F19C10C-424D-4A51-A5DA-7C62C4E83EFBQ26774212-F1AE891C-1504-4742-AD30-A8E2FD48F4B5Q26774916-6D95358B-9DA4-417F-8132-5827BFFE8EE6Q26779931-852D882F-629C-4E99-8659-A28C1983D43DQ26784590-38B41B58-1B20-4EC7-936E-2E1DBFD6DD4EQ26798198-55A58B38-AD46-4530-8EE2-198B9B38FB5BQ26823995-11ECB95D-D311-4D84-83E8-39E1BADD5484Q26824147-CFA159BB-CB86-4F9F-9CA2-6FF3A0B77BD9Q26825809-06A61225-B794-40AE-95CB-7C16D99842F7Q26849216-ECBAB240-BBBA-4B54-8E06-21FA8B53973EQ26851313-F6D2FD40-C5DC-42D3-B3C2-311FA80C3048Q26853232-DF1B1367-9548-458B-B169-CB640603E2FFQ26865904-79F99EEF-293B-4C88-9807-8A34AD83E414Q26995023-832CC096-D954-400F-B77A-EA154CDF0744Q27002524-F3D28E4C-78F4-48E5-9C07-77BB0F3775ADQ27011433-0E071597-C599-4E23-A413-6037DC46BDF7Q27013811-D5CE32F8-3ED5-4BCC-AB6F-C811F72767B0Q27027502-D0DA1323-EA06-48E4-BD1E-BA11EFAAAAAAQ27316304-7526EB23-F8CC-4F7F-9CFF-1691629D2220Q27317710-980EE2CA-292A-48CE-B6D1-0FA4FE35536CQ27331698-6AC6FDBB-B79F-48A6-9849-C8B3980CEC16Q27332350-87855BB3-23C8-43A7-BA8C-CD90A18C74B5Q28071384-02BA062C-F347-4A00-B7C5-2223047EAF6DQ28071388-EDA73164-DBE3-46EE-9934-B4890324B7BEQ28076101-0D4B1CEB-C2A0-4533-A32F-A94968890818Q28078154-18CAF632-E9E0-4F75-BDF6-1184952E128FQ28081844-9CDD69AB-D2C6-42E0-AFDD-82B0A4823C9E
P2860
Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells
@ast
Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells
@en
type
label
Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells
@ast
Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells
@en
prefLabel
Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells
@ast
Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells
@en
P2093
P3181
P356
P1433
P1476
Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells
@en
P2093
Brian K Theisen
David O Ferguson
Omer H Yilmaz
Riccardo Valdez
P2888
P304
P3181
P356
10.1038/NATURE04703
P407
P577
2006-04-05T00:00:00Z
P5875
P6179
1046950382